Cargando…

Isolation and Characterization of Tumor Cells from the Ascites of Ovarian Cancer Patients: Molecular Phenotype of Chemoresistant Ovarian Tumors

Tumor cells in ascites are a major source of disease recurrence in ovarian cancer patients. In an attempt to identify and profile the population of ascites cells obtained from ovarian cancer patients, a novel method was developed to separate adherent (AD) and non-adherent (NAD) cells in culture. Twe...

Descripción completa

Detalles Bibliográficos
Autores principales: Latifi, Ardian, Luwor, Rodney B., Bilandzic, Maree, Nazaretian, Simon, Stenvers, Kaye, Pyman, Jan, Zhu, Hongjian, Thompson, Erik W., Quinn, Michael A., Findlay, Jock K., Ahmed, Nuzhat
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3466197/
https://www.ncbi.nlm.nih.gov/pubmed/23056490
http://dx.doi.org/10.1371/journal.pone.0046858
_version_ 1782245645609861120
author Latifi, Ardian
Luwor, Rodney B.
Bilandzic, Maree
Nazaretian, Simon
Stenvers, Kaye
Pyman, Jan
Zhu, Hongjian
Thompson, Erik W.
Quinn, Michael A.
Findlay, Jock K.
Ahmed, Nuzhat
author_facet Latifi, Ardian
Luwor, Rodney B.
Bilandzic, Maree
Nazaretian, Simon
Stenvers, Kaye
Pyman, Jan
Zhu, Hongjian
Thompson, Erik W.
Quinn, Michael A.
Findlay, Jock K.
Ahmed, Nuzhat
author_sort Latifi, Ardian
collection PubMed
description Tumor cells in ascites are a major source of disease recurrence in ovarian cancer patients. In an attempt to identify and profile the population of ascites cells obtained from ovarian cancer patients, a novel method was developed to separate adherent (AD) and non-adherent (NAD) cells in culture. Twenty-five patients were recruited to this study; 11 chemonaive (CN) and 14 chemoresistant (CR). AD cells from both CN and CR patients exhibited mesenchymal morphology with an antigen profile of mesenchymal stem cells and fibroblasts. Conversely, NAD cells had an epithelial morphology with enhanced expression of cancer antigen 125 (CA125), epithelial cell adhesion molecule (EpCAM) and cytokeratin 7. NAD cells developed infiltrating tumors and ascites within 12–14 weeks after intraperitoneal (i.p.) injections into nude mice, whereas AD cells remained non-tumorigenic for up to 20 weeks. Subsequent comparison of selective epithelial, mesenchymal and cancer stem cell (CSC) markers between AD and NAD populations of CN and CR patients demonstrated an enhanced trend in mRNA expression of E-cadherin, EpCAM, STAT3 and Oct4 in the NAD population of CR patients. A similar trend of enhanced mRNA expression of CD44, MMP9 and Oct4 was observed in the AD population of CR patients. Hence, using a novel purification method we demonstrate for the first time a distinct separation of ascites cells into epithelial tumorigenic and mesenchymal non-tumorigenic populations. We also demonstrate that cells from the ascites of CR patients are predominantly epithelial and show a trend towards increased mRNA expression of genes associated with CSCs, compared to cells isolated from the ascites of CN patients. As the tumor cells in the ascites of ovarian cancer patients play a dominant role in disease recurrence, a thorough understanding of the biology of the ascites microenvironment from CR and CN patients is essential for effective therapeutic interventions.
format Online
Article
Text
id pubmed-3466197
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-34661972012-10-10 Isolation and Characterization of Tumor Cells from the Ascites of Ovarian Cancer Patients: Molecular Phenotype of Chemoresistant Ovarian Tumors Latifi, Ardian Luwor, Rodney B. Bilandzic, Maree Nazaretian, Simon Stenvers, Kaye Pyman, Jan Zhu, Hongjian Thompson, Erik W. Quinn, Michael A. Findlay, Jock K. Ahmed, Nuzhat PLoS One Research Article Tumor cells in ascites are a major source of disease recurrence in ovarian cancer patients. In an attempt to identify and profile the population of ascites cells obtained from ovarian cancer patients, a novel method was developed to separate adherent (AD) and non-adherent (NAD) cells in culture. Twenty-five patients were recruited to this study; 11 chemonaive (CN) and 14 chemoresistant (CR). AD cells from both CN and CR patients exhibited mesenchymal morphology with an antigen profile of mesenchymal stem cells and fibroblasts. Conversely, NAD cells had an epithelial morphology with enhanced expression of cancer antigen 125 (CA125), epithelial cell adhesion molecule (EpCAM) and cytokeratin 7. NAD cells developed infiltrating tumors and ascites within 12–14 weeks after intraperitoneal (i.p.) injections into nude mice, whereas AD cells remained non-tumorigenic for up to 20 weeks. Subsequent comparison of selective epithelial, mesenchymal and cancer stem cell (CSC) markers between AD and NAD populations of CN and CR patients demonstrated an enhanced trend in mRNA expression of E-cadherin, EpCAM, STAT3 and Oct4 in the NAD population of CR patients. A similar trend of enhanced mRNA expression of CD44, MMP9 and Oct4 was observed in the AD population of CR patients. Hence, using a novel purification method we demonstrate for the first time a distinct separation of ascites cells into epithelial tumorigenic and mesenchymal non-tumorigenic populations. We also demonstrate that cells from the ascites of CR patients are predominantly epithelial and show a trend towards increased mRNA expression of genes associated with CSCs, compared to cells isolated from the ascites of CN patients. As the tumor cells in the ascites of ovarian cancer patients play a dominant role in disease recurrence, a thorough understanding of the biology of the ascites microenvironment from CR and CN patients is essential for effective therapeutic interventions. Public Library of Science 2012-10-08 /pmc/articles/PMC3466197/ /pubmed/23056490 http://dx.doi.org/10.1371/journal.pone.0046858 Text en © 2012 Latifi et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Latifi, Ardian
Luwor, Rodney B.
Bilandzic, Maree
Nazaretian, Simon
Stenvers, Kaye
Pyman, Jan
Zhu, Hongjian
Thompson, Erik W.
Quinn, Michael A.
Findlay, Jock K.
Ahmed, Nuzhat
Isolation and Characterization of Tumor Cells from the Ascites of Ovarian Cancer Patients: Molecular Phenotype of Chemoresistant Ovarian Tumors
title Isolation and Characterization of Tumor Cells from the Ascites of Ovarian Cancer Patients: Molecular Phenotype of Chemoresistant Ovarian Tumors
title_full Isolation and Characterization of Tumor Cells from the Ascites of Ovarian Cancer Patients: Molecular Phenotype of Chemoresistant Ovarian Tumors
title_fullStr Isolation and Characterization of Tumor Cells from the Ascites of Ovarian Cancer Patients: Molecular Phenotype of Chemoresistant Ovarian Tumors
title_full_unstemmed Isolation and Characterization of Tumor Cells from the Ascites of Ovarian Cancer Patients: Molecular Phenotype of Chemoresistant Ovarian Tumors
title_short Isolation and Characterization of Tumor Cells from the Ascites of Ovarian Cancer Patients: Molecular Phenotype of Chemoresistant Ovarian Tumors
title_sort isolation and characterization of tumor cells from the ascites of ovarian cancer patients: molecular phenotype of chemoresistant ovarian tumors
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3466197/
https://www.ncbi.nlm.nih.gov/pubmed/23056490
http://dx.doi.org/10.1371/journal.pone.0046858
work_keys_str_mv AT latifiardian isolationandcharacterizationoftumorcellsfromtheascitesofovariancancerpatientsmolecularphenotypeofchemoresistantovariantumors
AT luworrodneyb isolationandcharacterizationoftumorcellsfromtheascitesofovariancancerpatientsmolecularphenotypeofchemoresistantovariantumors
AT bilandzicmaree isolationandcharacterizationoftumorcellsfromtheascitesofovariancancerpatientsmolecularphenotypeofchemoresistantovariantumors
AT nazaretiansimon isolationandcharacterizationoftumorcellsfromtheascitesofovariancancerpatientsmolecularphenotypeofchemoresistantovariantumors
AT stenverskaye isolationandcharacterizationoftumorcellsfromtheascitesofovariancancerpatientsmolecularphenotypeofchemoresistantovariantumors
AT pymanjan isolationandcharacterizationoftumorcellsfromtheascitesofovariancancerpatientsmolecularphenotypeofchemoresistantovariantumors
AT zhuhongjian isolationandcharacterizationoftumorcellsfromtheascitesofovariancancerpatientsmolecularphenotypeofchemoresistantovariantumors
AT thompsonerikw isolationandcharacterizationoftumorcellsfromtheascitesofovariancancerpatientsmolecularphenotypeofchemoresistantovariantumors
AT quinnmichaela isolationandcharacterizationoftumorcellsfromtheascitesofovariancancerpatientsmolecularphenotypeofchemoresistantovariantumors
AT findlayjockk isolationandcharacterizationoftumorcellsfromtheascitesofovariancancerpatientsmolecularphenotypeofchemoresistantovariantumors
AT ahmednuzhat isolationandcharacterizationoftumorcellsfromtheascitesofovariancancerpatientsmolecularphenotypeofchemoresistantovariantumors